These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14558934)

  • 21. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ; White BA
    J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of impurities level of perindopril tert-butylamine in tablets.
    Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
    J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of ceftazidime and impurities using high performance liquid chromatography].
    Jiang E; Hu C
    Se Pu; 2008 Jan; 26(1):75-9. PubMed ID: 18438029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation and determination of synthetic impurities of norfloxacin by reversed-phase high performance liquid chromatography.
    Nageswara Rao R; Nagaraju V
    J Pharm Biomed Anal; 2004 Mar; 34(5):1049-56. PubMed ID: 15019038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid liquid chromatographic determination of itraconazole and its production impurities.
    Wharton M; Geary M; Sweetman P; Curtin L; O'Connor N
    J Chromatogr Sci; 2014 Mar; 52(3):187-94. PubMed ID: 23476029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gradient HPLC test procedure for the determination of impurities and the synthetic precursors in 2-[4-(1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl)-phenyl]-2-methylpropionic acid.
    B'Hymer C
    J Chromatogr Sci; 2006 Apr; 44(4):200-4. PubMed ID: 16620518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
    Shaik JV; Saladi S; Sait SS
    J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid determination of minority organic acids in honey by high-performance liquid chromatography.
    Suárez-Luque S; Mato I; Huidobro JF; Simal-Lozano J; Sancho MT
    J Chromatogr A; 2002 May; 955(2):207-14. PubMed ID: 12075924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of an UPLC method for rapid determination of ibuprofen and diphenhydramine citrate in the presence of impurities in combined dosage form.
    Rao DD; Sait SS; Mukkanti K
    J Chromatogr Sci; 2011 Apr; 49(4):281-6. PubMed ID: 21439118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of reversed phase high performance liquid chromatographic method for determination of moxonidine in the presence of its impurities.
    Milovanović S; Otašević B; Zečević M; Zivanović L; Protić A
    J Pharm Biomed Anal; 2012 Feb; 59():151-6. PubMed ID: 22071445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a reversed phase liquid chromatographic method for analysis of pyridoxal-5'-phosphate and its impurities.
    Fouad Mansour M; Assefa M; El-Khouly A; Zhu P; Van Schepdael A; Adams E
    Electrophoresis; 2018 Oct; 39(20):2540-2549. PubMed ID: 29676797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a reversed-phase liquid chromatographic method for analysis of demeclocycline and related impurities.
    Kahsay G; Maxa J; Van Schepdael A; Hoogmartens J; Adams E
    J Sep Sci; 2012 Jun; 35(10-11):1310-8. PubMed ID: 22733511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous HPLC determination of nitrendipine and impurities of the process of synthesis.
    Marinkovic V; Agbaba D; Vladimirov S; Stankovic S
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):993-8. PubMed ID: 11248493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
    Chandrashekara KA; Udupi A; Reddy CG
    J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous determination of cations, zwitterions and neutral compounds using mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography.
    Li J; Shao S; Jaworsky MS; Kurtulik PT
    J Chromatogr A; 2008 Mar; 1185(2):185-93. PubMed ID: 18304563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
    Sharma N; Rao SS; Reddy AM
    J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of a process intermediate of celiprolol and its potential impurities by gradient high-performance liquid chromatography--application of high-low chromatography.
    Difeo TJ; Shuster JE
    J Pharm Biomed Anal; 1991; 9(10-12):823-8. PubMed ID: 1822200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.